Target Of Rapamycin (TOR) pathway has an evolutionary conserved role in the control of growth, metabolism, stress response, survival and ageing.

Currently "TOR de France" is a unique conference series in the world entirely devoted to field of "Target Of Rapamycin" signaling, nutrition, growth, metabolism, development. The "TOR de France" meeting gathers students, postdocs, research group leaders and medical doctors working on various aspects of TOR biology and the applications in medicine, pharmacology, human health. This pluridiplinary approach allows new and fruitful feedbacks on everyone's work and have proven to foster innovative collaborations.

After the success of the first editions in 2018, 2021 and 2023, the TOR de France has now a strong and growing international community. We are looking forward to meeting you for the fourth edition! Please visit the site in the spring 2024 for the program and registration.